Lushun Jiang

529 total citations
11 papers, 302 citations indexed

About

Lushun Jiang is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Lushun Jiang has authored 11 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 4 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Lushun Jiang's work include Hepatitis B Virus Studies (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Hepatitis C virus research (3 papers). Lushun Jiang is often cited by papers focused on Hepatitis B Virus Studies (4 papers), Liver Disease Diagnosis and Treatment (3 papers) and Hepatitis C virus research (3 papers). Lushun Jiang collaborates with scholars based in China and United States. Lushun Jiang's co-authors include Yunqing Qiu, Xuehang Jin, Xiaolan Xu, Li Wang, Zhe Wu, Li Wang, Zhe Wu, Li Zhang, Yan Lou and Wei Yu and has published in prestigious journals such as BMC Public Health, Biomedicine & Pharmacotherapy and Journal of Translational Medicine.

In The Last Decade

Lushun Jiang

11 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lushun Jiang China	6	106	59	55	50	36	11	302
Xuehang Jin China	6	99 0.9×	23 0.4×	55 1.0×	39 0.8×	32 0.9×	10	244
Yu Ri Im United Kingdom	7	60 0.6×	143 2.4×	35 0.6×	36 0.7×	28 0.8×	9	329
Darine Daher United States	12	71 0.7×	142 2.4×	39 0.7×	75 1.5×	34 0.9×	28	398
Golnar Karimian Netherlands	10	61 0.6×	63 1.1×	78 1.4×	38 0.8×	11 0.3×	12	351
Weiming Mou China	11	64 0.6×	18 0.3×	39 0.7×	70 1.4×	35 1.0×	30	235
Dongbok Shin South Korea	8	55 0.5×	24 0.4×	16 0.3×	82 1.6×	93 2.6×	11	270
Nikki R. Adler Australia	13	124 1.2×	61 1.0×	23 0.4×	180 3.6×	25 0.7×	31	389
Jingjuan Zhu China	12	147 1.4×	34 0.6×	47 0.9×	204 4.1×	194 5.4×	28	483
Thodsawit Tiyarattanachai Thailand	12	29 0.3×	109 1.8×	25 0.5×	37 0.7×	39 1.1×	23	310

Countries citing papers authored by Lushun Jiang

Since Specialization

Citations

This map shows the geographic impact of Lushun Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lushun Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lushun Jiang more than expected).

Fields of papers citing papers by Lushun Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lushun Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lushun Jiang. The network helps show where Lushun Jiang may publish in the future.

Co-authorship network of co-authors of Lushun Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Lushun Jiang. A scholar is included among the top collaborators of Lushun Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lushun Jiang. Lushun Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Lian, Xiang, et al.. (2024). Characteristics of Immunocytes and Cytokines in Patients with Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae in China. Infection and Drug Resistance. Volume 17. 719–725. 2 indexed citations

Yu, Wei, Xiang Lian, Lushun Jiang, et al.. (2024). Dynamic cytokine profiles of bloodstream infection caused by Klebsiella pneumoniae in China. Annals of Clinical Microbiology and Antimicrobials. 23(1). 79–79. 2 indexed citations

Xu, Xiaolan, et al.. (2023). Changing incidence of hepatitis B and persistent infection risk in adults: a population-based follow-up study from 2011 in China. BMC Public Health. 23(1). 256–256. 5 indexed citations

Xu, Xiaolan, et al.. (2023). HCC prediction models in chronic hepatitis B patients receiving entecavir or tenofovir: a systematic review and meta-analysis. Virology Journal. 20(1). 180–180. 2 indexed citations

Li, Zhang, Jing Liu, Xiangliu Chen, et al.. (2023). Enterococcus faecalis promotes the progression of colorectal cancer via its metabolite: biliverdin. Journal of Translational Medicine. 21(1). 72–72. 34 indexed citations

Xu, Xiaolan, et al.. (2021). The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool?. Journal of the Formosan Medical Association. 121(2). 454–466. 40 indexed citations

Xu, Xiaolan, Lushun Jiang, Liya Pan, et al.. (2021). Cost-Effectiveness of Hepatitis B Mass Screening and Management in High-Prevalent Rural China: A Model Study From 2020 to 2049. International Journal of Health Policy and Management. 11(10). 2115–2123. 5 indexed citations

Jiang, Lushun, Zhe Wu, Xiaolan Xu, et al.. (2021). Opportunities and challenges of artificial intelligence in the medical field: current application, emerging problems, and problem-solving strategies. Journal of International Medical Research. 49(3). 3619061085–3619061085. 104 indexed citations

Jiang, Lushun, Xuehang Jin, Zhe Wu, et al.. (2020). Inhibiting RRM2 to enhance the anticancer activity of chemotherapy. Biomedicine & Pharmacotherapy. 133. 110996–110996. 89 indexed citations

10.

Wang, Li, et al.. (2020). A novel multitarget kinase inhibitor BZG with potent anticancer activity in vitro and vivo enhances efficacy of sorafenib through PI3K pathways in hepatocellular carcinoma cells. Biomedicine & Pharmacotherapy. 125. 110033–110033. 8 indexed citations

11.

Wu, Zhe, Li Wang, Li Zhang, et al.. (2020). Identification of osalmid metabolic profile and active metabolites with anti-tumor activity in human hepatocellular carcinoma cells. Biomedicine & Pharmacotherapy. 130. 110556–110556. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact